Exec Director, Strategy Architect

Exec Director, Opportunity Strategy Architect Syneos Health® is a leading fully-integrated life sciences services organization built to accelerate customer success. We partner with innovators at every point across the drug development and commercialization continuum, helping them navigate complexity, anticipate change and accelerate progress. Every day we perform better because of how we work together, as one team, each the best at what we do.

We bring together talented experts across a broad spectrum of business critical corporate functions. Every role plays an essential part in enabling our customers to achieve their goals. Our teams are agile, collaborative, and committed to delivering—for each other, for our customers, and ultimately for the people who rely on the services we support.

• We are passionate about developing our people, through career development and progression; supportive and engaged line management; technical and therapeutic area training; peer recognition and total rewards program.
• We are committed to building an inclusive culture - where you can authentically be yourself. Central to this is our purpose - Driven to Deliver - which captures the passion of our colleagues to show up each day and shape solutions that have the ability to dramatically impact someone’s life.
• We are continuously building the company we all want to work for and our customers want to work with. Why? Because we know that when we bring together smart colleagues from across the world, we can shape the future of healthcare, driving impact for customers and defining the pace of patient progress.

Company Syneos Health is a leading, fully integrated biopharmaceutical solutions organization that partners with pharmaceutical and biotechnology companies to develop and commercialize new therapies. Formed in 2017 through the merger of INC Research and in Ventiv Health, the business combines clinical development and commercial capabilities within a single platform, supporting customers from early-stage trials through product launch and market adoption. With more than 25,000 employees globally and operations across North America, Europe, and Asia-Pacific, Syneos Health serves a broad mix of large pharmaceutical companies and emerging biotechnology organizations.

The company’s integrated model, global scale, therapeutic expertise, and long-standing customer relationships position it as a differentiated partner within the biopharma services ecosystem. Syneos Health was taken private in 2023 by a consortium of private equity investors after operating as a public company. Today, the business generates approximately $5 billion in annual revenue and is focused on defining its next phase of growth, including how it sharpens its strategic focus and evolves within an increasingly dynamic and technology-driven market environment.

The opportunity Syneos is building an Analytics Center of Excellence to improve how data, clinical insight, real-world evidence, feasibility, patient access, site strategy, and operational experience are brought into pre-award decision-making. The Opportunity Strategy Architect is the role that forces the organization to ask better questions before the proposal strategy is set. This person does not need to be the therapeutic expert or medical expert.

They must understand clinical trials and drug development well enough to identify when the stated approach does not make sense, when the data does not support the strategy, and when the team is defaulting to the traditional answer instead of the best answer.

The Opportunity Strategy Architect is the strategic conscience of the opportunity: the person who asks why, challenges assumptions,…